Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Nordhealth AS ( (DE:6E5) ) is now available.
Nordhealth AS, the Helsinki-based cloud healthcare SaaS provider for veterinary and therapy professionals, reported that primary insiders Charles MacBain and Didier Breton have purchased class A shares in the company. The move comes as Nordhealth continues to expand its international presence, with software used in more than 30 countries and a workforce of about 400 employees.
The insider share purchases signal management’s continued financial commitment to Nordhealth and may be interpreted as a vote of confidence in the company’s long-term growth trajectory. As the trades fall under EU and Norwegian market abuse and securities regulations, the company has disclosed the transactions in line with regulatory requirements, ensuring transparency for investors and other market participants.
More about Nordhealth AS
Nordhealth AS is a publicly listed, fast-growing cloud-based healthcare SaaS provider focused on digitalising care delivery. The company develops software platforms that enable veterinary and therapy professionals to manage clinical workflows and deliver better care experiences to patients. Its solutions are used by more than 60,000 professionals across 13,000 clinics and hospitals in over 30 countries, with a strong Nordic footprint and expanding international reach.
Headquartered in Helsinki, Finland, Nordhealth employs around 400 staff working remotely or from collaboration hubs. The company positions itself at the intersection of healthcare and technology, targeting the global veterinary and therapy practice management market with scalable, cloud-native products designed to support modern, data-driven clinical operations.
Average Trading Volume: 4,244
Current Market Cap: NOK2.1B
Find detailed analytics on 6E5 stock on TipRanks’ Stock Analysis page.

